<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30396986</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>11</Month>            <Day>13</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>13</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1791-7530</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>38</Volume>                    <Issue>11</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Anticancer research</Title>                <ISOAbbreviation>Anticancer Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia.</ArticleTitle>            <Pagination>                <MedlinePgn>6561-6564</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.21873/anticanres.13022</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Breast metastases from extra mammary tumors are extremely rare.</AbstractText>                <AbstractText Label="CASE REPORT" NlmCategory="METHODS">Here we report the case of a 50-year-old female with histologically-confirmed gastric cancer metastasis to the breast who was adequately treated with loco-regional hyperthermia plus standard second-line chemotherapy (paclitaxel plus ramucirumab). The best response achieved was a relatively long disease stabilization.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Chemotherapy plus regional hyperthermia has been shown to have a synergistic antitumor effect and possible favorable immunomodulatory effects. Such an approach merits further investigation especially for the treatment of rare superficial metastatic sites.</AbstractText>                <CopyrightInformation>CopyrightÂ© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Lucchetti</LastName>                    <ForeName>Jessica</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit, Tor Vergata University, Rome, Italy jess.lucchetti@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Formica</LastName>                    <ForeName>Vincenzo</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Giuliano</LastName>                    <ForeName>Greta</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Coletta</LastName>                    <ForeName>Deborah</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gargano</LastName>                    <ForeName>Letizia</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Morosetti</LastName>                    <ForeName>Daniele</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Diagnostic Imaging Department, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sileri</LastName>                    <ForeName>Pierpaolo</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Surgery Department, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Palmieri</LastName>                    <ForeName>Giampiero</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Anatomic Pathology Department, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Roselli</LastName>                    <ForeName>Mario</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit, Tor Vergata University, Rome, Italy.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D002363">Case Reports</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Anticancer Res</MedlineTA>            <NlmUniqueID>8102988</NlmUniqueID>            <ISSNLinking>0250-7005</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>D99YVK4L0X</RegistryNumber>                <NameOfSubstance UI="C543333">ramucirumab</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>P88XT4IS4D</RegistryNumber>                <NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006979" MajorTopicYN="N">Hyperthermia, Induced</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017239" MajorTopicYN="N">Paclitaxel</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast</Keyword>            <Keyword MajorTopicYN="N">case report</Keyword>            <Keyword MajorTopicYN="N">gastric cancer</Keyword>            <Keyword MajorTopicYN="N">metastasis</Keyword>            <Keyword MajorTopicYN="N">regional hyperthermia</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>10</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>10</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30396986</ArticleId>            <ArticleId IdType="pii">38/11/6561</ArticleId>            <ArticleId IdType="doi">10.21873/anticanres.13022</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>